nach oben

Innovative Infrastructure Solutions

Erschienen in:

01.12.2020 | Review

COVID-19 from mysterious enemy to an environmental detection process: a critical review

verfasst von: Lamis M. F. El-Baz, Khalid Z. Elwakeel, Ahmed M. Elgarahy

Erschienen in: Innovative Infrastructure Solutions | Ausgabe 3/2020

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

The recent global emergence of an unusual viral pneumonia of COVID-19 epidemic was firstly started in Wuhan city, Hubei province in China in December 2019. Regrettably, it is still sweeping the planet, and it cannot be controlled up till now. By May 2020, the unexpected spread of this disaster had caused more than 3,759,967 cases and 259,474 deaths in 114 countries from Asia to the Middle East, Europe, and the USA. Considering its fatal nature, it has evolved as a major challenge for the world. This is necessitating a quick and steep intervention in order to save millions of people’s lives across the globe. The knowledge about the nature and evolution of the COVID-19 virus in water, soils, and other environmental compartments can be addressed through wastewater and sewage. Wastewater-based epidemiology approach can be used as an early indicator of the infection within a specific population. The basic aim of this review article is trying to provide a prompt, and valuable reference guides about COVID-19. Some important questions were addressed, such as, its origin, transmission, clinical symptoms, diagnosis, environmental aspects, and the possible indoors and outdoors airborne transmission minimization strategies that may benefit specialists.

Vorheriger Artikel A holistic evaluation of human-induced LULCC and shoreline dynamics of El-Burullus Lagoon through remote sensing techniques

Nächster Artikel Experimental investigations on potential of brick-based building-derived materials for geotechnical applications

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Singhal T (2020) A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 87:281–286CrossRef

Yin Y, Wunderink RG (2018) MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 23:130–137CrossRef

Guo Y-R, Cao Q-D, Hong Z-S et al (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Mil Med Res 7:1–10. https://doi.org/10.1186/s40779-020-00240-0CrossRef

Vabret A, Mourez T, Gouarin S et al (2003) An outbreak of coronavirus OC43 respiratory infection in Normandy, France. Clin Infect Dis 36:985–989. https://doi.org/10.1086/374222CrossRef

Zhong NS, Zheng BJ, Li YM et al (2003) Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet 362:1353–1358. https://doi.org/10.1016/S0140-6736(03)14630-2CrossRef

Gerna G, Campanini G, Rovida F et al (2006) Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol 78:938–949. https://doi.org/10.1002/jmv.20645CrossRef

Gerna G, Percivalle E, Sarasini A et al (2007) Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients. J Clin Virol 38:244–250. https://doi.org/10.1016/j.jcv.2006.12.008CrossRef

Vabret A, Dina J, Gouarin S et al (2008) Human (non-severe acute respiratory syndrome) coronavirus infections in hospitalised children in France. J Paediatr Child Health 44:176–181. https://doi.org/10.1111/j.1440-1754.2007.01246.xCrossRef

Owusu M, Annan A, Corman VM et al (2014) Human coronaviruses associated with upper respiratory tract infections in three rural areas of Ghana. PLoS ONE. https://doi.org/10.1371/journal.pone.0099782CrossRef

10.

Lim Y, Ng Y, Tam J, Liu D (2016) Human coronaviruses: a review of virus–host interactions. Diseases 4:26. https://doi.org/10.3390/diseases4030026CrossRef

11.

Woo PCY, Lau SKP, Lam CSF et al (2012) Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol 86:3995–4008. https://doi.org/10.1128/jvi.06540-11CrossRef

12.

Bermingham A, Chand MA, Brown CS et al (2012) Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Eurosurveillance. https://doi.org/10.2807/ese.17.40.20290-enCrossRef

13.

Zaki AM, Van Boheemen S, Bestebroer TM et al (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820. https://doi.org/10.1056/NEJMoa1211721CrossRef

14.

Lu H, Stratton CW, Tang YW (2020) Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 92:401–402CrossRef

15.

Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513. https://doi.org/10.1016/S0140-6736(20)30211-7CrossRef

16.

Gorbalenya AE, Baker SC, Baric RS et al (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536–544CrossRef

17.

World Health Organisation (WHO) (2020) Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). WHO, Geneva, pp 1–6

18.

World Health Organisation (WHO) (2020) WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. WHO Dir Gen speeches 4

19.

Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92:418–423CrossRef

20.

Wu A, Peng Y, Huang B et al (2020) Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 27:325–328. https://doi.org/10.1016/j.chom.2020.02.001CrossRef

21.

Rosa GL, Bonadonna L, Lucentini L et al (2020) Coronavirus in water environments: occurrence, persistence and concentration methods—a scoping review. Water Res 179:115899CrossRef

22.

Sohrabi C, Alsafi Z, O’Neill N et al (2020) World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 76:71–76CrossRef

23.

Centers for Disease Control and Prevention (2020) How coronavirus spreads|CDC. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covidspreads.html?CDC_AA_refVal = https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Ftransmission.html. Accessed 3 May 2020

24.

Li Q, Guan X, Wu P et al (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382:1199–1207CrossRef

25.

Rothe C, Schunk M, Sothmann P et al (2020) Transmission of 2019-NCOV infection from an asymptomatic contact in Germany. N Engl J Med 382:970–971CrossRef

26.

Peng X, Xu X, Li Y et al (2020) Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci 12:9CrossRef

27.

Holland M, Zaloga DJ, Friderici CS (2020) COVID-19 personal protective equipment (PPE) for the emergency physician. Vis J Emerg Med 19:100740. https://doi.org/10.1016/j.visj.2020.100740CrossRef

28.

Center for Disease Control and Prevention (CDC) (2016) Transmission-based precautions|basics|infection control|CDC. CDC. https://www.cdc.gov/infectioncontrol/basics/transmission-based-precautions.html. Accessed 5 April 2020

29.

Radonovich LJ, Simberkoff MS, Bessesen MT et al (2019) N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. JAMA - J Am Med Assoc 322:824–833. https://doi.org/10.1001/jama.2019.11645CrossRef

30.

Lu CW, Liu XF, Jia ZF (2020) 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 395:e39CrossRef

31.

Belser JA, Rota PA, Tumpey TM (2013) Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev 77:144–156. https://doi.org/10.1128/mmbr.00058-12CrossRef

32.

To KK-W, Tsang OT-Y, Chik-Yan Yip C et al (2020) Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa149CrossRef

33.

Holshue ML, DeBolt C, Lindquist S et al (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med 382:929–936. https://doi.org/10.1056/NEJMoa2001191CrossRef

34.

Xiao F, Tang M, Zheng X et al (2020) Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology 158:1831-1833.e3. https://doi.org/10.1053/j.gastro.2020.02.055CrossRef

35.

Zhang W, Du RH, Li B et al (2020) Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 9:386–389. https://doi.org/10.1080/22221751.2020.1729071CrossRef

36.

Harrel SK, Molinari J (2004) Aerosols and splatter in dentistry: a brief review of the literature and infection control implications. J Am Dent Assoc 135:429–437. https://doi.org/10.14219/jada.archive.2004.0207CrossRef

37.

Liu L, Wei Q, Alvarez X et al (2011) Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of Rhesus macaques. J Virol 85:4025–4030. https://doi.org/10.1128/jvi.02292-10CrossRef

38.

Cleveland JL, Gray SK, Harte JA et al (2016) Transmission of blood-borne pathogens in US dental health care settings: 2016 update. J Am Dent Assoc 147:729–738. https://doi.org/10.1016/j.adaj.2016.03.020CrossRef

39.

Elsevier (2020) Novel coronavirus information center. Elsevier Connect, Amsterdam

40.

Center for Disease Control and Prevention (CDC) (2019) Symptoms of coronavirus|CDC. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. Accessed 6 May 2020

41.

Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/NEJMoa2002032CrossRef

42.

Fu L, Wang B, Yuan T et al (2020) Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. https://doi.org/10.1016/j.jinf.2020.03.041CrossRef

43.

Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5CrossRef

44.

Chan JFW, Kok KH, Zhu Z et al (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9:221–236. https://doi.org/10.1080/22221751.2020.1719902CrossRef

45.

Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. JAMA - J Am Med Assoc, China. https://doi.org/10.1001/jama.2020.1585CrossRef

46.

Zhu N, Zhang D, Wang W et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. https://doi.org/10.1056/NEJMoa2001017CrossRef

47.

Gupta R, Ghosh A, Singh AK, Misra A (2020) Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabet Metab Syndr Clin Res Rev 14:211–212CrossRef

48.

Chen X, Tian J, Li G, Li G (2020) Initiation of a new infection control system for the COVID-19 outbreak. Lancet Infect Dis 20:397–398. https://doi.org/10.1016/S1473-3099(20)30110-9CrossRef

49.

Bai L, Yang D, Wang X et al (2020) Chinese experts’ consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19). Clin eHealth 3:7–15. https://doi.org/10.1016/j.ceh.2020.03.001CrossRef

50.

Center for Disease Control and Prevention (CDC) (2020) How to protect yourself|CDC. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html. Accessed 8 May 2020

51.

World Health Organisation (WHO) (2020) Advice for public. WHO, Geneva

52.

El Zowalaty ME, Järhult JD (2020) From SARS to COVID-19: a previously unknown SARS-related coronavirus (SARS-CoV-2) of pandemic potential infecting humans—call for a one health approach. One Health. https://doi.org/10.1016/j.onehlt.2020.100124CrossRef

53.

Lu J, Milinovich GJ, Hu W (2016) A brief historical overview of emerging infectious disease response in China and the need for a one health approach in future responses. One Health 2:99–102. https://doi.org/10.1016/j.onehlt.2016.07.001CrossRef

54.

Shengen Visa Info (2020) Italy suspends visa issuance and all air traffic from China

55.

The Wall Street Journal (2020) U.S. imposes entry restrictions over coronavirus. https://www.wsj.com/articles/u-k-reports-first-coronavirus-cases-as-china-allies-limit-ties-11580467046. Accessed 8 May 2020

56.

57.

BBC (2020) Coronavirus: which countries have evacuated their citizens? https://www.bbc.com/news/world-asia-china-51312378. Accessed 8 May 2020

58.

BBC (2020) Coronavirus: more Britons evacuated from Wuhan on French flight. https://www.bbc.com/news/health-51345279. Accessed 8 May 2020

59.

The Wall Street Journal (2020) U.S. plans to evacuate more Americans by aircraft from Wuhan. https://www.wsj.com/articles/u-s-plans-another-wuhan-evacuation-flight-as-soon-as-next-week-11580380747. Accessed 8 May 2020

60.

Phelan AL, Katz R, Gostin LO (2020) The novel coronavirus originating in Wuhan, China: challenges for Global Health Governance. JAMA - J Am Med Assoc 323:709–710CrossRef

61.

France24 (2020) France bans gatherings of more than 1000 people to contain coronavirus. Fr. 24. https://www.france24.com/en/20200308-france-bans-gatherings-of-more-than-1-000-people-to-contain-coronavirus. Accessed 8 May 2020

62.

Ebrahim SH, Memish ZA (2020) COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia. Lancet 395:e48CrossRef

63.

Purcell LN, Charles AG (2020) An Invited Commentary on “World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)”: emergency or new reality? Int J Surg 76:111. https://doi.org/10.1016/j.ijsu.2020.03.002CrossRef

64.

Tanne JH, Hayasaki E, Zastrow M et al (2020) Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide. BMJ 368:m1090. https://doi.org/10.1136/bmj.m1090CrossRef

65.

Cohen J, Kupferschmidt K (2020) Countries test tactics in “war” against COVID-19. Science (80-.) 367:1287–1288CrossRef

66.

Amin S (2020) Egyptian government’s anti-virus plan met with mixed reactions. Al-Monitor. https://www.al-monitor.com/pulse/originals/2020/03/egypt-coronavirus-curfew-sisi-measures-protests.html#ixzz6Ixo0qtBO. Accessed 7 April 2020

67.

Online A (2020) Egypt’s SSCHR reviews national response towards coronavirus pandemic—politics—Egypt—Ahram Online. Ahram Online. http://english.ahram.org.eg/NewsContent/1/64/366717/Egypt/Politics-/Egypt’s-SSCHR-reviews-national-response-towards-co.aspx. Accessed 8 April 2020

68.

France-Presse A (2020) New 1000-bed Wuhan hospital takes its first coronavirus patients|World news|The Guardian. Guard

69.

Innovation R and (2020) Coronavirus: EU mobilises €10 million for research|European Commission. European Commission. https://ec.europa.eu/info/news/coronavirus-eu-mobilises-eur10-million-for-research-2020-jan-31_en. Accessed 8 May 2020

70.

Devices VM (2020) Co-diagnostics launches RUO test for novel coronavirus. Verdict Medical Devices. https://www.medicaldevice-network.com/news/co-diagnostics-ruo-test/. Accessed 8 May 2020

71.

Devices VM (2020) Primerdesign launches new molecular test for novel coronavirus. Verdict Medical Devices. https://www.medicaldevice-network.com/news/primerdesign-molecular-test-coronavirus/. Accessed 8 May 2020

72.

BBC (2020) Coronavirus: UK donates £20 m to speed up vaccine. BBC News

73.

Jean S-S, Lee P-I, Hsueh P-R (2020) Treatment options for COVID-19: the reality and challenges. J Microbiol Immunol Infect. https://doi.org/10.1016/j.jmii.2020.03.034CrossRef

74.

Gurwitz D (2020) Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. https://doi.org/10.1002/ddr.21656

75.

Sun ML, Yang JM, Sun YP, Su GH (2020) Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 43:219–222. https://doi.org/10.3760/cma.j.issn.1001-0939.2020.03.016CrossRef

76.

Ghaffari H, Tavakoli A, Moradi A et al (2019) Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine. J Biomed Sci. https://doi.org/10.1186/s12929-019-0563-4CrossRef

77.

Hemilä H (1997) Vitamin C intake and susceptibility to pneumonia. Pediatr Infect Dis J 16:836–837CrossRef

78.

Caly L, Druce JD, Catton MG et al (2020) The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. https://doi.org/10.1016/j.antiviral.2020.104787CrossRef

79.

Chen L, Xiong J, Bao L, Shi Y (2020) Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 20:398–400CrossRef

80.

World Health Organisation (WHO) (2020) Infection prevention and control during halth care when novel coronavirus (nCOV) infection is suspected. WHO 38:71–86. https://doi.org/10.1016/j.ccm.2016.11.007CrossRef

81.

McKinney KR, Gong YY, Lewis TG (2006) Environmental transmission of SARS at Amoy Gardens. J Environ Health 68:26–30

82.

Liew MF, Siow WT, Yau YW, See KC (2020) Safe patient transport for COVID-19. Crit Care 24:94CrossRef

83.

Peng J, Ren N, Wang M, Zhang G (2020) Practical experiences and suggestions on the eagle-eyed observer, a novel promising role for controlling nosocomial infection of the COVID-19 outbreak. J Hosp, InfectCrossRef

84.

Lapolla P, Lee R, Mingoli A (2020) Wastewater as a red flag in COVID-19 spread. Public Health 185:26CrossRef

85.

Randazzo W, Truchado P, Cuevas-Ferrando E, Simon P, Allende A, Sanchez G (2020) SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area. Water Res 181:115942CrossRef

86.

Ahmed W, Angel N, Edson J et al (2020) First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community. Sci Total Environ 728:138764CrossRef

87.

Italian National Institute of Health (ISS). CS N 30/2020—wastewater can be an in-dicator of Covid-19 outbreaks. https://www.iss.it/web/guest/primo-piano/-/asset_publisher/o4oGR9qmvUz9/content/id/5344257. Accessed 1 May 2020 (in Italian)

88.

Wurtzer S, Marechal V, Mouchel JM, Moulin L (2020) Time course quantitative detection of SARS-CoV-2 in Parisian waste waters correlates with COVID-19 confirmed cases. medRxiv. https://doi.org/10.1101/2020.04.12.20062679CrossRef

89.

Murakami M, Hata A, Honda R et al (2020) Letter to the editor: wastewater-based epidemiology can overcome representativeness and stigma issues related to COVID-19. Environ Sci Technol 54:5311CrossRef

90.

Huang Z, Huang J, Gu Q et al (2020) Optimal temperature zone for the dispersal of COVID-19. Sci Total Environ 736:139487CrossRef

91.

Biktasheva IV (2020) Role of a habitat’s air humidity in Covid-19 mortality. Sci Total Environ 736(2020):138763CrossRef

92.

Buonanno G, Stabile L, Morawska L (2020) Estimation of airborne viral emission: Quanta emission rate of SARS-CoV-2 for infection risk assessment. Environ Int 141:105794CrossRef

93.

Zandifar A, Badrfam R (2020) Iranian mental health during the COVID-19 epidemic. Asian J, Psychiatry, p 51

94.

Berger ZD, Evans NG, Phelan AL, Silverman RD (2020) COVID-19: control measures must be equitable and inclusive. BMJ 368 (2020) M No1141

95.

World Health Organisation (WHO) (2020) COVID-19 situation reports. WHO. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 9 May 2020

Titel: COVID-19 from mysterious enemy to an environmental detection process: a critical review
verfasst von: Lamis M. F. El-Baz
Khalid Z. Elwakeel
Ahmed M. Elgarahy
Publikationsdatum: 01.12.2020
Verlag: Springer International Publishing
Erschienen in: Innovative Infrastructure Solutions / Ausgabe 3/2020
Print ISSN: 2364-4176
Elektronische ISSN: 2364-4184
DOI: https://doi.org/10.1007/s41062-020-00334-7

Springer Professional

Abstract

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Springer Professional "Wirtschaft"

Weitere Artikel der Ausgabe 3/2020

Utilization of industrial waste—based geopolymers as a soil stabilizer—a review

Strength and durability characteristics of binary blended recycled coarse aggregate concrete containing microsilica and metakaolin

Possible effects and reactions between leachate and different clay material types

Experimental studies on single reinforced stone columns with various positions of geotextile

Influence of recycled concrete aggregates and blended cements on the mechanical properties of pervious concrete

The COVID-19 pandemic: biological evolution, treatment options and consequences